Ampicillin–Sulbactam and Amikacin Used as Second-Line Antibiotics for Patients with Culture-Negative Peritonitis
Author:
Affiliation:
1. Nephrology Division Queen Mary Hospital University of Hong Kong Hong Kong
2. Department of Medicine Department of Microbiology Queen Mary Hospital University of Hong Kong Hong Kong
Publisher
SAGE Publications
Subject
Nephrology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/089686080802800520
Reference6 articles.
1. Peritoneal Dialysis-Related Infections Recommendations: 2005 Update
2. Usefulness of 23S rRNA Amplification by PCR in the Detection of Bacteria in CAPD Peritonitis
3. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci
4. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci
5. Differing outcomes of gram-positive and gram-negative peritonitis
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility;Journal of Nephrology;2023-08-07
2. Inconsistencies in 2022 ISPD peritonitis guidelines;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-05
3. Reply to: Inconsistencies in 2022 ISPD peritonitis guidelines;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-05
4. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2022-03
5. Inconsistencies in ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment and the ISPD Catheter-Related Infection Recommendations: 2017 Update;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3